IBIO
iBioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IBIO Profile
Ibio, Inc.
A biotechnology company that utilizes artificial intelligence and advanced computational biology to develop next-generation biopharmaceutical products
11750 Sorrento Valley Road, Suite 200, San Diego, CA 92121
--
IBio, Inc., incorporated under the laws of Delaware on April 17, 2008 as iBioPharma, Inc., merged with Biotechnologies, Inc., New Jersey on July 25, 2008 and changed its name to iBio, Inc. on August 10, 2009. IBio is a preclinical stage biotechnology company that uses the power of artificial intelligence (AI) to develop precision antibodies. The company's proprietary technology stack is designed to minimize downstream development risks by employing AI-guided epitope guidance and monoclonal antibody (mAb) optimization.
